Alnylam Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ALNY Alnylam Pharmaceuticals Inc
HLBZ Helbiz Inc
SRNE Sorrento Therapeutics Inc
OKTA Okta Inc
AAPL Apple Inc
CBTTF Cathedra Bitcoin Inc
IPVF InterPrivate III Financial Partners Inc
MFD Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income
SLNG Stabilis Solutions Inc
THO Thor Industries Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It is developing therapeutics based on ribonucleic acid interference (RNAi). Its pipeline includes four products and multiple late and early-stage investigational RNAi therapeutics, that is focused in four strategic therapeutic areas (STArs): Genetic Medicines; Cardio-Metabolic Diseases; Hepatic Infectious Diseases; and CNS/Ocular Diseases. Its RNAi-based medicines include ONPATTRO (patisiran), GIVLAARI (givosiran), OXLUMO (lumasiran) and Leqvio (inclisiran). ONPATTRO is an intravenously administered RNAi therapeutic targeting transthyretin amyloidosis. GIVLAARI is used to reduce induced liver aminolevulinic acid synthase 1 messenger RNA (mRNA), to reduce toxins associated with attacks and other disease manifestations of acute hepatic porphyria. OXLUMO is an RNAi therapeutic targeting hydroxyacid oxidase 1 for the treatment of primary hyperoxaluria type 1. Leqvio is used for the treatment of adults with hypercholesterolemia.

Postmarket

Last Trade
Delayed
$124.96
-0.64 (-0.51%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$125.60
Day's Change
-1.15 (-0.91%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
129.06
Day's Low
125.02
Volume
(Light)
Volume:
330,301

10-day average volume:
838,866
330,301
  • Prev Close
    126.75
  • Today's Open
    127.19
  • Day's Range
    125.02-129.06
  • Avg Vol (10-day)
    838.9K
  • Last (time)
    4:00p ET 05/26/22
  • Last (size)
    10
  • 52-Wk Range
    117.58 - 212.00
    LowHigh
  • (10/14/21 - 05/12/22)
    6.82%
  • 49.5%
  • Market Cap
    15.2B
  • Shares Outstanding
    120.8M
  • -7.48
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 98.82
  • (% of float 05/15/22)
    4.88

Latest News

May 24, 2022
7:00 am ET
BusinessWire
May 23, 2022
7:00 am ET
BusinessWire
May 04, 2022
8:00 am ET
BusinessWire
April 28, 2022
8:00 am ET
BusinessWire
April 14, 2022
8:30 am ET
BusinessWire
April 05, 2022
4:00 pm ET
BusinessWire
April 04, 2022
7:30 am ET
BusinessWire
March 22, 2022
8:00 am ET
BusinessWire
March 17, 2022
7:30 am ET
BusinessWire
March 16, 2022
7:30 am ET
BusinessWire
March 01, 2022
7:00 am ET
BusinessWire
February 28, 2022
4:00 pm ET
BusinessWire
7:00 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.